Skip to main navigationSkip to main content
The University of Southampton
Southampton Clinical Trials Unit

ATAFUTI Trial

Trial Name

ATAFUTI - Alternative Treatments of Adult Female Urinary Tract Infection: a double blind, placebo controlled, factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen.

Description

A Phase III trial investigating alternative treatments for adult female urinary tract infection.

Objectives

Primary Objective:

Secondary Objectives:

Design

Multicentre, factorial (2 x 2), randomised double blind placebo controlled trial of Uva ursi and open trial of ibuprofen advice.

Participants will be randomised to one of four groups:

All participants will be issued a prescription for delayed antibiotics. This prescription will be used if symptoms worsen or after three to five days if symptoms are not improving (most symptoms should have settled by this time).

Participants will take the study medication for three days or up to five days and will complete a symptom diary for up to two weeks. A notes review will be undertaken at three months.

A sample of participants will be invited to take part in qualitative interviews to find out about their views on antibiotics and alternative treatments for UTIs.

A sample of GPs from participating surgeries will also have qualitative interviews to elicit attitudes towards alternative treatments.

Status

Complete

Population

376 Adult women (18-70) presenting to primary care, with suspected lower urinary tract infection (suspected by GP or nurse practitioner) 

Publications

Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial

Contact details

All Trial enquiries should be addressed to ctu@soton.ac.uk

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×